NanoSanguis is a company founded to bring to the market first safe and effective red blood cell substitute. The company has its origin in Warsaw University of Technology. We have started as a team of PhD candidates developing technology of oxygen therapeutics. In December 2015, together with two VC capitals – Start Venture Poland and Giza Polish Ventures, we created NanoSanguis to give synthetic blood every human in need regardless of their origin, social status and religious beliefs.
Founded date: 2015